These findings suggest that CCRK functions as a major signaling hub in obesity-associated hepatocarcinogenesis, providing insights into therapeutic strategies to reduce tumor burden from the worldwide obesity epidemic. Here, CDK20 is linked to obesity due to melanocortin 4 receptor deficiency.